News

November 16, 2018November 16, 2018

Phase 1 Trial to Test AL002, Targeting Brain’s Immune System, as Way of Treating Alzheimer’s

News

Alector’s candidate immune system-targeting therapy for Alzheimer’s disease, called AL002, will be evaluated for safety and tolerability in a first Phase 1 clinical trial, the company announced. AL002 is an antibody ... Read more

November 14, 2018November 14, 2018

Comorbidities Common and Disabling in Alzheimer’s and Dementia Patients, UK Study Reports

News

People with dementia, including those with Alzheimer’s disease, often are also living with one or more other chronic diseases that significantly impact their quality of life, according to a ... Read more

November 12, 2018November 12, 2018

Beta-amyloid’s Key Role in Alzheimer’s Toxic Clumps and Need for Personalized Medicine Focus of Talk

News

Increasing evidence places beta-amyloid aggregates at the center of the toxic protein clumps and neuroinflammation that drive Alzheimer’s, two experts in this disease said, and a personalized, combination treatment ... Read more

November 9, 2018November 9, 2018

New Challenge Offers Scientists $4M in Prize Money to Find Cause of Alzheimer’s

News

A retired U.S. executive has given $5 million to the University of Texas at San Antonio (UTSA) College of Sciences to establish a contest that challenges scientists to find ... Read more

November 7, 2018November 7, 2018

Chronic Inflammation May Underlie Higher Alzheimer’s Risk in ApoE4 Carriers, Study Shows

News

Chronic, low-level inflammation enhances the risk of Alzheimer’s disease among ApoE4 gene carriers, the major genetic risk factor for the late-onset form of the disorder, a study shows. The study, “Association of ... Read more

November 5, 2018November 5, 2018

Herpes Virus Increases Alzheimer’s Risk, but Antivirals May Be Effective Therapy, Review Study Reports

News

Herpes simplex virus type 1 (HSV1) may be linked to Alzheimer’s development, and antiviral therapies lower the risk of senile dementia in patients with severe herpes infections, according to a review ... Read more

November 2, 2018November 2, 2018

Continued Physical Activity Benefits Older Adults at Risk of Alzheimer’s, Study Suggests

News

Continued activity improves physical health in older adults at risk of Alzheimer’s, which in turn can potentially reduce their risk of developing the disease, according to results of an ... Read more

October 31, 2018October 31, 2018

Anavex 2-73 Slows Cognitive Decline in Alzheimer’s Patients, Phase 2 Extension Trial Shows

News

Treatment with Anavex‘s investigational therapy Anavex 2-73 significantly reduces cognitive decline in people with Alzheimer’s disease and sustains their ability to perform daily activities, according to interim data from a ... Read more

October 29, 2018October 29, 2018

Stem Cell Therapy Shows Evidence of Aiding Cognition, Lowering Amyloid Load in Mouse Model of Alzheimer’s

News

Neuralstem’s stem cell therapy for Alzheimer’s disease was found to improve cognition and lessen the load of amyloid-beta plaques in a mouse model of the disease, a study reports, ... Read more

October 26, 2018October 26, 2018

CavoGene Pursues New Therapy for Neurodegenerative Diseases, Including Alzheimer’s

News

CavoGene LifeSciences is going to explore a new gene therapy, called SynCav1, that may represent an alternative and attractive strategy to treat several neurodegenerative diseases, including Alzheimer’s. This follows ... Read more

Pin It on Pinterest